| Literature DB >> 16247439 |
Jaye Chin-Dusting1, Jacques Mizrahi, Garry Jennings, Desmond Fitzgerald.
Abstract
This paper reviews models of academic-pharmaceutical industry collaboration and debates the value of such partnerships so that those contemplating an alliance can reflect a priori on the purpose, nature and process that will provide a constructive outcome. The scope is confined to the biomedical discipline, because collaborations in other fields, such as physics and engineering, have not suffered as a result of the concerns associated with biomedicine.Entities:
Mesh：
Year: 2005 PMID： 16247439 DOI： 10.1038/nrd1879
Source DB: PubMed Journal: Nat Rev Drug Discov ISSN： 1474-1776 Impact factor: 84.694